Cryptoxanthin

Your Token Count0

Sign in to Purchase/Download Documents

Sign in / Register

Focus Your Research

Click any topic below to filter + focus research
18 Diseases Researched for Cryptoxanthin
6 Pharmacological Actions Researched for Cryptoxanthin

View the Evidence:
17 Abstracts with Cryptoxanthin Research

[+]
Pubmed Data : Int J Food Sci Nutr. 2016 Jun 30:1-13. Epub 2016 Jun 30. PMID: 27356952
Study Type : Meta Analysis
Additional Links
Pharmacological Actions : Antioxidants
Additional Keywords : Risk Reduction
[+]
Pubmed Data : Gynecol Oncol. 2010 Sep;118(3):289-94. Epub 2010 Jun 18. PMID: 20691333
Study Type : Human Study
Additional Links
Pharmacological Actions : Antioxidants
[+]
Pubmed Data : Asia Pac J Clin Nutr. 2007;16 Suppl 1:437-42. PMID: 17392146
Study Type : Human Study
Additional Links
Pharmacological Actions : Anticarcinogenic Agents
Additional Keywords : Risk Reduction
[+]
Pubmed Data : Am J Clin Nutr. 2015 Sep 9. Epub 2015 Sep 9. PMID: 26354537
Study Type : Human Study
Additional Links
Diseases : Hearing Loss
Additional Keywords : Risk Reduction
[+]
Pubmed Data : Int J Cancer. 2005 Mar 1;113(6):1010-4. PMID: 15514967
Study Type : Human Study
Additional Links
Pharmacological Actions : Chemopreventive
Additional Keywords : Risk Reduction
[+]
Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Biomed Biotechnol. 2012 ;2012:516981. Epub 2011 Nov 24. PMID: 22174562
Study Type : Animal Study
[+]
Pubmed Data : Biol Pharm Bull. 2011;34(3):311-7. PMID: 21372377
Study Type : Animal Study
Additional Links
Pharmacological Actions : Neuroprotective Agents
[+]
Pubmed Data : Mol Nutr Food Res. 2017 Oct ;61(10). Epub 2017 Jul 18. PMID: 28544535
Study Type : Animal Study
Additional Links
Pharmacological Actions : Cardioprotective
[+]
Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Biol Pharm Bull. 2017 ;40(7):1116-1120. PMID: 28674255
Study Type : Animal Study
Additional Links
Substances : Cryptoxanthin
Diseases : Osteoarthritis
Pharmacological Actions : Prophylactic Agents
[+]
Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : J Pharmacol Sci. 2015 Sep ;129(1):72-7. Epub 2015 Aug 22. PMID: 26342276
Study Type : Animal Study
Additional Links
Substances : Cryptoxanthin
Additional Keywords : Supplementation
[+]
Article Publish Status : This is a free article. Click here to read the complete article.
Pubmed Data : Cancer Prev Res (Phila). 2013 Apr ;6(4):309-20. Epub 2012 Dec 28. PMID: 23275008
Study Type : Animal Study
[+]
Pubmed Data : Food Chem Toxicol. 2017 Sep ;107(Pt A):270-279. Epub 2017 Jul 6. PMID: 28689061
Study Type : Animal Study
[+]
Pubmed Data : Biosci Biotechnol Biochem. 2017 May ;81(5):1014-1017. Epub 2017 Jan 23. PMID: 28110620
Study Type : Animal Study
Additional Links
Substances : Cryptoxanthin
Diseases : Neuropathic Pain
[+]
Pubmed Data : Biol Pharm Bull. 2005 Nov;28(11):2142-5. PMID: 16272706
Study Type : In Vitro Study
Additional Links
Substances : Cryptoxanthin, Zinc
Pharmacological Actions : Anabolic Agents
Additional Keywords : Natural Substance Synergy
[+]
Pubmed Data : Mol Cell Biochem. 2004 Mar;258(1-2):137-44. PMID: 15030178
Study Type : In Vitro Study
Additional Links
Pharmacological Actions : Anticarcinogenic Agents
[+]
Pubmed Data : Jpn J Cancer Res. 1999 Oct;90(10):1061-5. PMID: 10595732
Additional Links
Substances : Cryptoxanthin
[+]
Pubmed Data : Biol Pharm Bull. 2005 Sep;28(9):1766-9. PMID: 16141556
Additional Links
Substances : Cryptoxanthin

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2017 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.